People who carry the APOE2 variant of the apolipoprotein E gene generally have a longer lifespan and a lower risk of developing Alzheimer’s disease. Although this advantage has been known for some time, its biological mechanisms remained unclear.

New Insights into the Role of APOE2

A recent study published in the journal Aging Cell suggests that APOE2 helps protect neuronal DNA and prevents cellular aging. Senescence is a state in which damaged and poorly functioning cells accumulate, becoming more common with age and linked to neurodegeneration. The study’s findings indicate that APOE’s influence extends beyond its well-known role in cholesterol transport, and that different gene variants may determine the brain’s ability to maintain and repair its genetic material over time.

Comparing APOE Variants

There are three common APOE variants: APOE2, APOE3, and APOE4. They differ by just two amino acids, yet have distinct effects on brain aging. APOE4 is considered the most significant genetic risk factor for late-onset Alzheimer’s disease, while APOE2 is associated with increased longevity and a reduced risk of dementia.

To study the impact of APOE variants on neuronal aging, researchers used human induced pluripotent stem cells genetically modified only at the APOE locus. These cells were differentiated into two types of neurons: inhibitory GABAergic and excitatory glutamatergic neurons. The study also examined hippocampal tissue from aged mice carrying human APOE2, APOE3, or APOE4 genes.

DNA Protection and Resistance to Aging

The research showed that neurons with APOE2 accumulate less DNA damage. Gene expression analysis revealed that GABAergic neurons with APOE2 activate pathways related to DNA repair and damage response, while neurons with APOE4 display patterns associated with Alzheimer’s disease. Direct measurements of DNA strand breaks confirmed that APOE2 neurons had significantly less damage compared to other variants.

Additionally, APOE2 neurons were more resistant to senescence. When exposed to radiation or the chemotherapy drug doxorubicin, both of which cause DNA damage, APOE2 neurons exhibited lower levels of senescence markers (including p16 and CRYAB), smaller nucleoli, and better-preserved nuclear architecture, indicating healthier internal cell structure.

Potential for Transferring the Protective Effect

Experiments showed that adding recombinant APOE2 protein to APOE4 neurons reduced DNA damage signals after irradiation. This suggests that some of APOE2’s protective effects can be transferred, not just inherited by those with the gene variant.

Confirmation in Mouse Models

Mouse experiments yielded similar results: aged animals with APOE2 had smaller nucleoli, higher levels of the nuclear protein Lamin A/C, and better-preserved heterochromatin in the hippocampus compared to mice with APOE3 or APOE4. These features are linked to healthy brain cell aging and support the findings observed in human neurons.

A New Understanding of APOE’s Role

DNA damage and cellular senescence are increasingly recognized as key factors in aging and age-related diseases, including Alzheimer’s. This study connects a major longevity gene to two of the most actively studied hallmarks of aging—the ability of neurons to protect their genome and resist cellular aging.

Therapeutic Perspectives

The study’s results suggest that approaches aimed at enhancing DNA repair or removing senescent cells from the brain could replicate some of APOE2’s natural benefits. Such strategies may one day help people at higher risk, particularly those carrying the APOE4 variant.

Further research is planned to explore the mechanisms by which APOE2 stabilizes the nuclear envelope and boosts DNA repair, as well as to search for compounds that mimic APOE2’s effects or targeted DNA repair methods to protect people with APOE4—the group at greatest genetic risk for Alzheimer’s disease.